Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 63629-1990
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 63629-1990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
The text describes a graph showing the proportion of patients with relapse over time from randomization in a clinical trial comparing the effectiveness of a placebo versus Duloxetine delayed-release capsules. The x-axis indicates the time in days, and the y-axis represents the percentage of patients experiencing relapse, ranging from 0% to 10%. It can be observed that the group treated with Duloxetine had a lower proportion of relapse cases compared to the placebo group.*
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Not available.*
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
The text indicates data on percentage of patients improved through a medication called DUL administered once daily. The percentage improvements are not given clearly, but present in the form of scattered numbers. The last line shows the percent improvement in pain from the baseline. However, it is not clear what the baseline value represents. Therefore, the available text provides insufficient information to make a useful description.*
Figure 9 (Duloxetine 09)
Figure 10 (Duloxetine 10)
This is a chart that displays the percentage of patients improved with respect to the placebo and a drug called DUL60/120mg taken once daily. The x-axis shows increasing numbers from 0 to 100 in increments of 10, and the y-axis shows the percent improvement in pain from baseline using the BOCF measurement method. The chart shows that the DUL60/120mg drug has a higher percentage of patients experiencing an improvement in pain compared to the placebo.*
Label (Lbl636291990)
This is a description of a medication called NILD in capsule form. Each capsule contains Duloxetine Hydrochloride, USP 20 mg. It is advised to keep this medication out of children's reach, store in a tight light-resistant container, and keep it tightly closed. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F). It is dispensed in the form of 90 capsules with NDC code 63629-1990-1 and is prescription-only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
